Small Arms Market to Reach USD 13.41 Billion by 2031, Driven by Defense Modernization and Next-Generation Weapon Programs, Reports Mordor Intelligence

Mordor Intelligence forecasts the global small arms market will expand from $10.75 billion in 2026 to $13.41 billion by 2031, a 4.53% CAGR. Growth is expected to be supported by defense modernization and procurement programs, including the US Army's Next Generation Squad Weapon initiative, alongside steady civilian demand for personal-protection firearms and related accessories. Asia-Pacific local-production initiatives and North American military and civilian demand are identified as key regional supports.

Analysis

This is not a near-term earnings catalyst for SWBI or RGR: the cited industry growth rate is below the nominal revenue growth needed to offset the civilian firearms sector's historically sharp demand cycles. The investable question is whether unit demand is stabilizing after channel inventory normalization; optics-ready compact-pistol mix can help gross margin through higher accessory attach rates, but neither public issuer has enough military exposure for overseas procurement to materially alter consolidated results in the next 12 months.

The more consequential second-order effect is caliber migration and platform replacement. A shift toward higher-performance rifle systems increases recurring ammunition, optics and components spend, favoring ammunition and accessory suppliers more than the listed consumer-gun manufacturers. For SWBI and RGR, competitive intensity remains the central margin risk: a modest demand recovery can quickly become promotional if distributors rebuild inventory ahead of actual sell-through, limiting operating leverage despite better volumes.

Over 6-18 months, domestic-content preferences in India and other Asia-Pacific markets are more likely to exclude US civilian-firearm brands than create export upside. COLT is private/illiquid as an equity proxy, so the relevant public read-through is limited. Treat third-party market-size estimates as low-conviction until corroborated by NICS-adjusted sell-through, distributor inventory days, and management commentary on average selling prices rather than shipment growth.

Contrarian view: consensus may overvalue any defense-modernization narrative for SWBI/RGR while underweighting the setup for a civilian-demand rebound if inventory reaches trough levels. That is a tactical, not structural, long thesis; it fails if promotional activity persists or quarterly gross margins do not recover despite rising shipments.

Key Decisions for Investors

• No immediate directional trade on the report alone; maintain SWBI and RGR as watchlist names until the next earnings release provides distributor-inventory and ASP evidence. A report-driven move should be faded absent a guidance increase.
• For a 1-3 month tactical setup, favor long RGR versus short SWBI only if RGR reports stable-to-rising gross margin and lower channel inventory; RGR's cleaner balance sheet makes it the better rebound vehicle. Exit the pair if RGR margin misses or SWBI shows materially faster inventory liquidation.
• For 6-18 month defense exposure, use diversified aerospace/defense primes rather than SWBI/RGR to express procurement modernization; the public civilian-firearm names lack sufficient contract visibility and export access to justify a defense multiple re-rating.
• Set alerts on NICS-adjusted demand, retailer promotions, and inventory turns. Initiate a civilian-firearms long only after two consecutive months of improving sell-through and evidence that gross margin is recovering; otherwise elevated promotional risk argues for staying neutral.